Constitutive Activation of STAT5A Promotes Human Hematopoietic Stem Cell Self-Renewal and Erythroid Differentiation
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Activation of the transcription factor signal transducer and activator of transcription (STAT)5 is involved in various aspects of hematopoiesis, affecting cell proliferation, differentiation, and cell survival. Constitutive activation of STAT5 has also been associated with leukemic transformation. We overexpressed the constitutively active mutant STAT5A(1*6) in human cord blood CD34+ cells and evaluated the effects on the hematopoietic potential of stem cells in a variety of in vitro and in vivo systems. The observed phenotypic changes were correlated with differential gene expression patterns induced by STAT5A(1*6). Our data indicate that a persistent activation of STAT5A in human hematopoietic stem and progenitor cells results in their enhanced self-renewal and diverts differentiation to the erythroid lineage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“We found JAK signaling to be indispensable for broad HSC differentiation capacity per se by influencing proliferative properties of the cells, which is in line with earlier findings that JAK/ STAT signaling promotes proliferation and self-renewal of HSCs [42].”
From PKCδ-Induced PU.1 Phosphorylation Promotes Hematopoietic Stem Cell Differentiation to Dendritic Cells (2011) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864 · cited 1×
“Evidence is now accumulating that suggests that acute leukemias are clonal disorders in which blastic cells have stem cell self-renewal characteristics with a concomitant block in differentiation toward mature blood cells (52, 53).”
BackgroundA cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783 · cited 1×
“Evidence is now accumulating that suggests that acute leukemias are clonal disorders in which blastic cells have stem cell self-renewal characteristics with a concomitant block in differentiation toward mature blood cells (52, 53).”
BackgroundSTATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201 · cited 2×
“Signal transduction pathways involved in STAT activation have been studied in great detail, but typically involve JAK-mediated phosphorylation of tyrosine residues in the SH2 domain of STATs, enabling STAT dimerization, nuclear translocation, and binding to response elements in promoters of target genes (11, 12).”
BackgroundA clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617 · cited 1×
“The process of hematopoietic differentiation involves the generation of multilineage progenitors that are restricted to either the myeloid or lymphoid lineages (the common myeloid progenitor [1] and the common lymphoid progenitor [2]), and further differentiation of these pluripotent cells generates mature erythroid,…”
BackgroundIdentification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253 · cited 1×
“The process of hematopoietic differentiation involves the generation of multilineage progenitors that are restricted to either the myeloid or lymphoid lineages (the common myeloid progenitor [1] and the common lymphoid progenitor [2]), and further differentiation of these pluripotent cells generates mature erythroid,…”
BackgroundA role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159 · cited 1×
“The WNT3A/ -catenin (9) and sonic hedgehog (10) pathways have also been shown to promote murine HSC self-renewal and oligoclonal lymphomyeloid differentiation potential in vivo.”
BackgroundBmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F. (2003) · Nature · doi:10.1038/nature01587 · Cited by 1,871 · cited 3×
“By loss of function (gene targeting) or gain of function (ectopic expression) experiments, a number of transcription factors have been suggested to be involved in HSC self-renewal, including HOXB4 (4), NOTCH1 (5), and BMI1 (6, 7).”
BackgroundHeissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A. S., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00754-7 · Cited by 1,751 · cited 2×
“Bone marrow ablation induces the release of soluble KL, enabling bone marrow–repopulating cells to translocate to a permissive vascular niche, favoring differentiation and reconstitution of the stem/progenitor cell pool (44).”
BackgroundResultSelf-citationBmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452 · cited 3×
“By loss of function (gene targeting) or gain of function (ectopic expression) experiments, a number of transcription factors have been suggested to be involved in HSC self-renewal, including HOXB4 (4), NOTCH1 (5), and BMI1 (6, 7).”
BackgroundBiology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A., & Weissman, I. L. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141007 · Cited by 997 · cited 1×
“The process of hematopoietic differentiation involves the generation of multilineage progenitors that are restricted to either the myeloid or lymphoid lineages (the common myeloid progenitor [1] and the common lymphoid progenitor [2]), and further differentiation of these pluripotent cells generates mature erythroid,…”
Background
Cited by
van de Laar, L., Coffer, P. J., & Woltman, A. M. (2012) · Blood · doi:10.1182/blood-2011-11-370130 · Cited by 358
Acute Myeloid Leukemia Stem Cells
DICK, J. E. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1349.001 · Cited by 189
HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
Marubayashi, S., Koppikar, P., Taldone, T., Abdel-Wahab, O., West, N., Bhagwat, N., Caldas-Lopes, E., Ross, K. N., Gönen, M., Gozman, A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42442 · Cited by 184
“We then used gene set enrichment analysis (GSEA) to assess the effects of PU-H71, JAK2 kinase inhibitor treatment, and combined PU-H71/JAK2 kinase inhibitor treatment on experimentally and computationally derived JAK-STAT gene expression signatures (52).”
MethodKato, Y., Iwama, A., Tadokoro, Y., Shimoda, K., Minoguchi, M., Akira, S., Tanaka, M., Miyajima, A., Kitamura, T., & Nakauchi, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042541 · Cited by 179
“A recent study showed that persistent activation of STAT5A in human cord blood CD34 cells enhances their capacity to repopulate nonobese diabetic/SCID mice in the short term and promotes erythroid differentiation (11).”
BackgroundResultRizo, A., Olthof, S., Han, L., Vellenga, E., de Haan, G., & Schuringa, J. J. (2009) · Blood · doi:10.1182/blood-2009-03-209734 · Cited by 164
“CFC and LTC-IC assays on MS-5 stromal cells were performed as previously described.(33) Briefly, for the CFC assays, 1000 GFP-sorted cells were plated in methylcellulose directly after transduction and 10.”
MethodSelf-citationMining for JAK–STAT mutations in cancer
Constantinescu, S. N., Girardot, M., & Pecquet, C. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.002 · Cited by 167
Harir, N., Pecquet, C., Kerenyi, M. A., Sonneck, K., Kovačic, B., Nyga, R., Brevet, M., Dhennin, I., Gouilleux‐Gruart, V., Beug, H., et al. (2006) · Blood · doi:10.1182/blood-2006-01-029918 · Cited by 138
Wang, X., Yang, L., Wang, Y.-C., Xu, Z.-R., Feng, Y., Zhang, J., Wang, Y., & Xu, C.-R. (2020) · Cell Research · doi:10.1038/s41422-020-0378-6 · Cited by 126
Takeda, A., Goolsby, C. L., & Yaseen, N. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0458 · Cited by 142
Xenograft models for normal and malignant stem cells
Goyama, S., Wunderlich, M., & Mulloy, J. C. (2015) · Blood · doi:10.1182/blood-2014-11-570218 · Cited by 129
Differences and similarities between cancer and somatic stem cells: therapeutic implications
Rossi, F., Noren, H., Jove, R., Beljanski, V., & Grinnemo, K.-H. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02018-6 · Cited by 121
STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas
Walker, S. R., Nelson, E. A., & Frank, D. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209775 · Cited by 136
“…in the upregulation of a variety of STAT5 target genes and markers of terminal differentiation, with a coincident downregulation of BCL6 expression (Schuringa et al., 2004), suggesting the possibility that STAT5 may regulate BCL6 expression either directly or indirectly during differentiation.”
BackgroundInfluentialStat5 activation enables erythropoiesis in the absence of EpoR and Jak2
Grebien, F., Kerenyi, M. A., Kovacic, B., Kolbe, T., Becker, V., Dolznig, H., Pfeffer, K., Klingmüller, U., Müller, M., Beug, H., et al. (2008) · Blood · doi:10.1182/blood-2007-07-102848 · Cited by 120
Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
Harir, N., Boudot, C., Friedbichler, K., Sonneck, K., Kondo, R., Martin-Lannerée, S., Kenner, L., Kerenyi, M., Yahiaoui, S., Gouilleux-Gruart, V., et al. (2008) · Blood · doi:10.1182/blood-2007-09-115477 · Cited by 115
Rizo, A., Vellenga, E., de Haan, G., & Schuringa, J. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl175 · Cited by 127
“Enforced activation of STAT5A in human CD34þ cells resulted in elevated self-renewal which was associated with an improved interaction with the microenvironment (87).”
BackgroundSelf-citationLong-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1
Rizo, A., Dontje, B., Vellenga, E., de Haan, G., & Schuringa, J. J. (2008) · Blood · doi:10.1182/blood-2007-08-106666 · Cited by 106
Self-citationLi, Y., Vecchiarelli-Federico, L. M., Li, Y., Egan, S. E., Spaner, D., Hough, M. R., & Ben‐David, Y. (2012) · Blood · doi:10.1182/blood-2011-09-378687 · Cited by 108
STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells
Schepers, H., van Gosliga, D., Wierenga, A. T. J., Eggen, B. J. L., Schuringa, J. J., & Vellenga, E. (2007) · Blood · doi:10.1182/blood-2006-08-039073 · Cited by 110
Self-citationDing, Z., Shi, H., Aboelella, N. S., Fesenkova, K., Park, E.-J., Liu, Z., Pei, L., Li, J., McIndoe, R., Xu, H., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba5962 · Cited by 95
Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells
van Gosliga, D., Schepers, H., Rizo, A., van der Kolk, D. M., Vellenga, E., & Schuringa, J. J. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.07.001 · Cited by 94
Self-citationTumor Suppression by Phospholipase C-β3 via SHP-1-Mediated Dephosphorylation of Stat5
Xiao, W., Hong, H., Kawakami, Y., Kato, Y., Wu, D., Yasudo, H., Kimura, A., Kubagawa, H., Bertoli, L. F., Davis, R. S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.018 · Cited by 88
“Constitutive activation of Stat5 in human cord blood CD34+ cells enhances their capacity to repopulate NOD/SCID mice and promotes erythroid differentiation (Schuringa et al., 2004).”
Maximal STAT5-Induced Proliferation and Self-Renewal at Intermediate STAT5 Activity Levels
Wierenga, A. T. J., Vellenga, E., & Schuringa, J. J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01025-08 · Cited by 103
Self-citationGough, S. M., Lee, F., Yang, F., Walker, R. L., Zhu, Y. J., Pineda, M. A., Onozawa, M., Chung, Y. J., Bilke, S., Wagner, E. K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0419 · Cited by 90
“which is important in HSC self-renewal and differentiation programs and a co-factor of the Hoxa9/Meis1 transcription activation complex (33, 34).”
Gomez‐Puerto, M. C., Folkerts, H., Wierenga, A. T. J., Schepers, K., Schuringa, J. J., Coffer, P. J., & Vellenga, E. (2016) · Stem Cells · doi:10.1002/stem.2347 · Cited by 94
Self-citationSignal Transduction of Oncogenic Flt3
Choudhary, C., Müller‐Tidow, C., Berdel, W. E., & Serve, H. L. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05090 · Cited by 98
“For example, expression of a constitutively active STAT5 (caSTAT5) in human CD34+ cells led to the self-renewal of early stem cells and to the formation of cobblestone areas in long-term bone marrow cultures, a good surrogate parameter of early progenitor cell expansion [79].”
BackgroundCsf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5
Liu, F., Kunter, G. M., Krem, M. M., Eades, W. C., Cain, J. A., Tomasson, M. H., Hennighausen, L. G., & Link, D. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32704 · Cited by 93
“org Volume 118 Number 3 March 2008 951 potential progenitors ex vivo (37, 40).”
BackgroundAntonelli, A., Noort, W. A., Jaques, J., de Boer, B., de Jong-Korlaar, R., Brouwers-Vos, A. Z., Lubbers-Aalders, L., van Velzen, J. F., Bloem, A. C., Yuan, H., et al. (2016) · Blood · doi:10.1182/blood-2016-05-719021 · Cited by 91
“CD34(1) cells were enriched or CD3(1) cells were depleted by using a magnetically activated cell-sortingCD34progenitor kit or automaticallybyusinganautoMACS separator (Miltenyi Biotech) as described previously.(3,20) Additional methods are described in the supplemental Data, available on the BloodWeb site.”
MethodSelf-citationBMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells
Rizo, A., Horton, S. J., Olthof, S., Dontje, B., Ausema, A., van Os, R., van den Boom, V., Vellenga, E., de Haan, G., & Schuringa, J. J. (2010) · Blood · doi:10.1182/blood-2010-02-270660 · Cited by 83
Self-citationTeofili, L., Martini, M., Cenci, T., Petrucci, G., Torti, L., Storti, S., Guidi, F., Leone, G., & Larocca, L. M. (2007) · Blood · doi:10.1182/blood-2007-01-069237 · Cited by 83
“Median, range 54 (24-83) 56 (20-84) 65 (57-79)”
Converging pathways in leukemogenesis and stem cell self-renewal
Moore, M. A. S. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.04.011 · Cited by 92
“The role of Stat5 activation in the Flt3ITD phenotype was evaluated using a constitutively activated double mutant of Stat5a (Stat5a(1*6)) that we transduced into CD34 cells [189].”
BackgroundMethodSelf-citationPark, H. J., Li, J., Hannah, R., Biddie, S., Leal‐Cervantes, A. I., Kirschner, K., Flores Santa Cruz, D., Sexl, V., Göttgens, B., & Green, A. R. (2016) · The EMBO Journal · doi:10.15252/embj.201592383 · Cited by 79
“Overexpression of constitutively active STAT5A gives rise to multilineage leukemia (Kato et al , 2005; Moriggl et al , 2005), hematopoietic stem and progenitor cell (HSPC) expansion, and enhanced erythropoiesis (Schuringa et al , 2004).”
Tsai, H., Jiang, S. S., Hung, W.-C., Borthakur, G. M., Lin, S.-F., Pemmaraju, N., Jabbour, E. J., Bomalaski, J. S., Chen, Y., Hsiao, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10542-4 · Cited by 84
Enforced Expression of NUP98-HOXA9 in Human CD34+ Cells Enhances Stem Cell Proliferation
Chung, K. Y., Morrone, G., Schuringa, J. J., Plasilova, M. L., Shieh, J.-H., Zhang, Y., Zhou, P., & Moore, M. A. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0706 · Cited by 75
Self-citationThe effect of cantharidins on leukemic stem cells
Dorn, D. C., Kou, C. A., Png, K. J., & Moore, M. A. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.24157 · Cited by 75
“Cantharidin also targeted pathways of other leukemia-associ- ated mutations such as activating mutations of Flt3, which differ from the ligand-stimulated wild-type Flt3.”
BackgroundSelf-citationAzkanaz, M., López, A. R., de Boer, B., Huiting, W., Angrand, P., Vellenga, E., Kampinga, H. H., Bergink, S., Martens, J. H. A., Schuringa, J. J., et al. (2019) · eLife · doi:10.7554/elife.45205 · Cited by 77
“CB CD34+ cells, K562, HeLa, and HEK293T cells were transduced as described previously (Horton et al., 2013; Schuringa et al., 2004; van den Boom et al., 2013).”
MethodSelf-citationThe JAK-STAT pathway and hematopoietic stem cells from the JAK2 V617F perspective
Staerk, J., & Constantinescu, S. N. (2012) · JAK-STAT · doi:10.4161/jkst.22071 · Cited by 86
Chen, A. Y., Kleiboeker, S. B., & Qiu, J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002088 · Cited by 76
“However, over-activation of STAT5A does not induce GATA1 expression significantly [57].”
BackgroundMolecular Mechanisms Underlying FIP1L1-PDGFRA–Mediated Myeloproliferation
Buitenhuis, M., Verhagen, L. P., Cools, J., & Coffer, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4183 · Cited by 70
“critical for the induction of differentiation in various hematopoietic lineages including eosinophils, neutrophils (20), and erythrocytes (21).”
BackgroundIdentification of HIF2α as an important STAT5 target gene in human hematopoietic stem cells
Fátrai, S., Wierenga, A. T. J., Daenen, S. M. G. J., Vellenga, E., & Schuringa, J. J. (2011) · Blood · doi:10.1182/blood-2010-08-303669 · Cited by 79
Self-citationBCL-2 expression is mainly regulated by JAK/STAT3 pathway in human CD34+ hematopoietic cells
Sepúlveda, P., Encabo, A., Carbonell‐Uberos, F., & Miñana, M. D. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402007 · Cited by 65
Nabinger, S. C., Li, X. J., Ramdas, B., He, Y., Zhang, X., Zeng, L., Richine, B. M., Bowling, J. D., Fukuda, S., Goenka, S., et al. (2012) · Leukemia · doi:10.1038/leu.2012.308 · Cited by 60
“Bcl-XL is particularly relevant to the current studies as its expression has been shown to contribute to leukemogenesis (53, 54), to be upregulated in primitive hematopoietic progenitors expressing constitutively activated STAT5 (55), and to be downregulated in hematopoietic progenitors bearing knockdown of Shp2 expre…”
BackgroundConstitutive nuclear import of latent and activated STAT5a by its coiled coil domain
Iyer, J. K., & Reich, N. C. (2007) · The FASEB Journal · doi:10.1096/fj.07-8965com · Cited by 67
Chung, K. Y., Morrone, G., Schuringa, J. J., Wong, B. Y., Dorn, D. C., & Moore, M. A. S. (2004) · Blood · doi:10.1182/blood-2003-12-4445 · Cited by 54
Self-citationSchuringa, J. J., Wu, K., Morrone, G., & Moore, M. A. S. (2004) · Stem Cells · doi:10.1634/stemcells.2004-0033 · Cited by 56
Self-citationMoore, M. A. S., Dorn, D. C., Schuringa, J. J., Chung, K. Y., & Morrone, G. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.01.018 · Cited by 53
Self-citationMontano‐Almendras, C. P., Essaghir, A., Schoemans, H. M., Varis, I., Noël, L. A., Velghe, A. I., Latinne, D., Knoops, L., & Demoulin, J. (2012) · Haematologica · doi:10.3324/haematol.2011.047530 · Cited by 54
“In addition, STAT5 is required but not sufficient to induce human CD34 cell differentiation into eosinophils.(38,39) Using pharmacological inhibitors and a mutant IκB, we show here that NF-κB also contributes to the proliferation and differentiation of CD34 cells transduced with TPβ.”
BackgroundWierenga, A. T. J., Schepers, H., Moore, M. A. S., Vellenga, E., & Schuringa, J. J. (2006) · Blood · doi:10.1182/blood-2005-11-4608 · Cited by 54
Self-citationSignal control of hematopoietic stem cell fate: Wnt, Notch, and Hedgehog as the usual suspects
Campbell, C., Risueno, R. M., Salati, S., Guezguez, B., & Bhatia, M. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328303b9df · Cited by 52
Wood, A. D., Chen, E., Donaldson, I. J., Hattangadi, S. M., Burke, K. A., Dawson, M. A., Miranda‐Saavedra, D., Lodish, H. F., Green, A. R., & Göttgens, B. (2009) · Blood · doi:10.1182/blood-2009-02-206573 · Cited by 53
Olthof, S. G. M., Fátrai, S., Drayer, A. L., Tyl, M. R., Vellenga, E., & Schuringa, J. J. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0899 · Cited by 52
Self-citationLeskov, I. B., Pallasch, C. P., Drake, A. C. B., Iliopoulou, B. P., de Souza, A. P. D., Shen, C.-H., Schweighofer, C. D., Abruzzo, L. V., Frenzel, L. P., Wendtner, C. ‐., et al. (2012) · Oncogene · doi:10.1038/onc.2012.117 · Cited by 49
“This stands in contrast to other recent studies involving the introduction of defined oncogenic perturbations into human hematopoietic stem cells, where engraftment of these cells into immunodeficient recipient mice has resulted in variable disease penetrance or non-malignant phenotypes (27-31).”
Schepers, H., Wierenga, A. T. J., van Gosliga, D., Eggen, B. J. L., Vellenga, E., & Schuringa, J. J. (2007) · Blood · doi:10.1182/blood-2006-10-052175 · Cited by 53
Self-citationHamdorf, M., Berger, A., Schüle, S., Reinhardt, J., & Flory, E. (2011) · Stem Cells · doi:10.1002/stem.564 · Cited by 46
Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model
Sontakke, P., Carretta, M., Jaques, J., Brouwers-Vos, A. Z., Lubbers-Aalders, L., Yuan, H., de Bruijn, J. D., Martens, A. C., Vellenga, E., Groen, R. W. J., et al. (2016) · Leukemia · doi:10.1038/leu.2016.108 · Cited by 49
Self-citationConstitutive activation of zebrafish Stat5 expands hematopoietic cell populations in vivo
Lewis, R. S., Stephenson, S. E. M., & Ward, A. C. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2005.11.003 · Cited by 45
Varricchio, L., Masselli, E., Alfani, E., Battistini, A., Migliaccio, G., Vannucchi, A. M., Zhang, W., Rondelli, D., Godbold, J., Ghinassi, B., et al. (2011) · Blood · doi:10.1182/blood-2010-07-296921 · Cited by 47
Carretta, M., de Boer, B., Jaques, J., Antonelli, A., Horton, S. J., Yuan, H., de Bruijn, J. D., Groen, R. W. J., Vellenga, E., & Schuringa, J. J. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.04.008 · Cited by 42
“Cells isolated from patient #1 were enriched for CD34 as previously described [31,32].”
Self-citationSTAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells
Schepers, H., Wierenga, A. T. J., Vellenga, E., & Schuringa, J. J. (2012) · JAK-STAT · doi:10.4161/jkst.19316 · Cited by 42
“16 This enhanced self-renewal was only observed in bone marrow stromal cocultures, but not in cytokine-driven liquid culture conditions.”
InfluentialSelf-citationJAK-STAT and AKT pathway-coupled genes in erythroid progenitor cells through ontogeny
Čokić, V. P., Bhattacharya, B., Beleslin‐Čokić, B. B., Noguchi, C. T., Puri, R. K., & Schechter, A. N. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-116 · Cited by 41
“A recent report revealed that a persistent activation of transcription factor/signaling protein STAT5A in human hematopoietic stem and progenitor cells favored their erythroid differentiation [35].”
BackgroundThe USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia
Maat, H., Atsma, T. J., Hogeling, S. M., López, A. R., Jaques, J., Olthuis, M., de Vries, M. P., Gravesteijn, C., Brouwers-Vos, A. Z., van der Meer, N. K., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102435 · Cited by 42
Self-citationFátrai, S., Schepers, H., Tadema, H., Vellenga, E., Daenen, S. M. G. J., & Schuringa, J. J. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.04.015 · Cited by 38
“Transfection was performed as described previously [16,17].”
MethodInfluentialSelf-citationSTAT5A regulates DNMT3A in CD34+/CD38− AML cells
Takeuchi, A., Nishioka, C., Ikezoe, T., Yang, J., & Yokoyama, A. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.05.006 · Cited by 37
“In addition, a persistent activation of STAT5A in human hematopoietic stem cells (HSCs) and progenitor cells results in their enhanced self-renewal and diverts differentiation to the erythroid lineage [7].”
BackgroundSoliera, A. R., Mariani, S. A., Audia, A., Lidonnici, M. R., Addya, S., Ferrari‐Amorotti, G., Cattelani, S., Manzotti, G., Fragliasso, V., Peterson, L. F., et al. (2012) · Leukemia · doi:10.1038/leu.2012.19 · Cited by 36
Beer, P. A., Knapp, D. J. H. F., Miller, P. H., Kannan, N., Sloma, I., Heel, K., Babovic, S., Bulaeva, E., Rabu, G. M., Terry, J., et al. (2014) · Blood · doi:10.1182/blood-2014-06-581173 · Cited by 35
“In this preliminary screen, 4 of the 15 cDNAs tested had significantly marked and sustained growth-promoting effects on the transduced CP-CML cells (Figure 1B-C and supplemental Figure 1).(27,28) Three of these 4 cDNAs (encoding c-MYC, NUP98-HOXA9, and KRAS T58I) have been previously implicated in advanced-phase myelo…”
BackgroundSTAT5 Is Crucial to Maintain Leukemic Stem Cells in Acute Myelogenous Leukemias Induced by MOZ-TIF2
Tam, W. F., Hähnel, P. S., Schüler, A., Lee, B. H., Okabe, R. O., Zhu, N., Pante, S. V., Raffel, G. D., Mercher, T., Wernig, G., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0255 · Cited by 34
Han, L., Wierenga, A. T. J., Geugien, M., van de Lande, K., Vellenga, E., & Schuringa, J. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007989 · Cited by 32
“In the MEP, STAT5 fulfils an important antiapoptotic role by upregulating Bcl-Xl [11,35,36], although a more direct role in initiating erythroid commitment might exist as well [15].”
BackgroundSelf-citationKennedy, J. A., Barabé, F., Patterson, B. J., Bayani, J., Squire, J. A., Barber, D. L., & Dick, J. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604902103 · Cited by 31
Lidonnici, M. R., Audia, A., Soliera, A. R., di Prisco, M., Ferrari‐Amorotti, G., Waldron, T. J., Donato, N. J., Zhang, Y., Martinez, R. V. P., Holyoake, T. L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1667 · Cited by 36
Nishioka, C., Ikezoe, T., Takeuchi, A., Nobumoto, A., Tsuda, M., & Yokoyama, A. (2015) · Leukemia · doi:10.1038/leu.2015.219 · Cited by 30
Varricchio, L., Tirelli, V., Masselli, E., Ghinassi, B., Saha, N., Besmer, P., & Migliaccio, A. R. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0676 · Cited by 30
“In the case of mKITL, low levels of EB amplification associated with maturation may be explained by absence of rapid ERK activation, which inhibits proliferation [30,31], and retention of sustained ERK and reduced STAT5 activation, both of which sustain maturation [30,31,34,35].”
IL4 blockade of inducible regulatory T cell differentiation: The role of Th2 cells, Gata3 and PU.1
Hadjur, S., Bruno, L., Hertweck, A., Cobb, B. S., Taylor, B., Fisher, A. G., & Merkenschlager, M. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.11.001 · Cited by 30
Scobie, L., Hector, R. D., Grant, L., Bell, M., Nielsen, A. A., Meikle, S., Philbey, A., Thrasher, A. J., Cameron, E. R., Blyth, K., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.59 · Cited by 29
Chiarella, E., Carrà, G., Scicchitano, S., Codispoti, B., Mega, T., Lupia, M., Pelaggi, D., Marafioti, M. G., Aloisio, A., Giordano, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114795 · Cited by 30
Self-citationWierenga, A. T. J., Vellenga, E., & Schuringa, J. J. (2010) · Blood · doi:10.1182/blood-2009-10-250894 · Cited by 32
Self-citationDrug Target Optimization in Chronic Myeloid Leukemia Using Innovative Computational Platform
Chuang, R. J., Hall, B. A., Benqué, D., Cook, B., Ishtiaq, S. S., Piterman, N., Taylor, A. S., Vardi, M. Y., Koschmieder, S., Göttgens, B., et al. (2015) · Scientific Reports · doi:10.1038/srep08190 · Cited by 29
Hua, W.-K., Chang, Y., Yao, C., Hwang, S., Chang, C.-Y., & Lin, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056715 · Cited by 23
“Intracellular signaling pathways such as the JAK/STAT [3], mitogen-activated protein kinase (MAPK) [4] and PI3 kinase/Akt [5] cascades have been shown to mediate these extracellular signals.”
BackgroundWidespread presence of bone marrow–like hematopoietic stem cell niche in invertebrate skeletons
Lian, S., Hu, N., Chen, X., Dai, X., Zhu, X., Qiao, R., Liu, S., Lu, Y., Zhang, F., Sun, F., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw0958 · Cited by 21
Hricik, T., Federici, G., Zeuner, A., Alimena, G., Tafuri, A., Tirelli, V., Varricchio, L., Masiello, F., Ciaffoni, F., Vaglio, S., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23487 · Cited by 21
“For example, CD341 cells isolated from cord blood, cultured on murine stromal cells, and transfected with an activating STAT5A construct, demonstrate increased self-renewal and selective maturation toward the erythroid lineage [3].”
BackgroundMitochondrial Dysfunction in Human Leukemic Stem/Progenitor Cells upon Loss of RAC2
Capala, M. E., Maat, H., Bonardi, F., van den Boom, V., Kuipers, J., Vellenga, E., Giepmans, B. N. G., & Schuringa, J. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128585 · Cited by 20
“CFC assays were performed as previously described [36].”
MethodSelf-citationHan, L., Schuringa, J. J., Mulder, A. B., & Vellenga, E. (2010) · Annals of Hematology · doi:10.1007/s00277-010-0948-7 · Cited by 20
“Colony-forming cell (CFC) assay was performed as previously described [21].”
MethodSelf-citationYunis, E. J., Romero, V. A., Diaz‐Griffero, F., Zúñiga, J., & Koka, P. S. (2007) · PubMed · Cited by 20
Rozenveld-Geugien, M., Baas, I. O., van Gosliga, D., Vellenga, E., & Schuringa, J. J. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.02.006 · Cited by 19
Self-citationInfluence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways
Sonawala, K., Ramalingam, S., & Sellamuthu, I. (2022) · Cells · doi:10.3390/cells11213492 · Cited by 19
“The JAK-STAT3 signaling pathway induces tumorigenesis through stimulating pre-metastatic niche, inflammation, and stem cells cross-talk [54].”
BackgroundGroh, M., Fenwarth, L., Labro, M., Boudry, A., Fournier, É., Wémeau, M., Marceau‐Renaut, A., Oliveira, R. D. D., Abraham, J., Barry, M., et al. (2024) · American Journal of Hematology · doi:10.1002/ajh.27306 · Cited by 19
“28 Although the presence of a mutation involving the JAK-STAT pathway was associated with impaired survival in univariate analysis, statistical significance disappeared in multivariate analysis.”
BackgroundMaintenance of hematopoietic stem cells by tyrosine-unphosphorylated STAT5 and JAK inhibition
Williams, M., Wang, X., Bastos, H. P., Grondys-Kotarba, G., Johnson, C., Mende, N., Calderbank, E. F., Wantoch, M., Park, H. J., Wu, Q., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014046 · Cited by 19
“57 Moreover, both STAT5 knockdown 55 and constitutively active STAT5A overexpression 27,28 have been reported to increase HSPC differentiation.”
Sontakke, P., Koczula, K. M., Jaques, J., Wierenga, A. T. J., Brouwers-Vos, A. Z., Pruis, M. G. M., Günther, U. L., Vellenga, E., & Schuringa, J. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153226 · Cited by 20
“Data were compared to transcriptomes of various other human leukemia models we had generated over the years, including CB CD34+ cells transduced with MLL-AF9 [32], FLT3-ITD [40], NUP98-HOXA9 [34], STAT5A [13,30,36,41] and KRASG12V [38] (Fig 1A, S1 Table).”
ResultSelf-citationThe Transcription Factor B-Cell Lymphoma (BCL)-6 Modulates Pancreatic β-Cell Inflammatory Responses
Igoillo‐Esteve, M., Gurzov, E. N., Eizirik, D. L., & Cnop, M. (2010) · Endocrinology · doi:10.1210/en.2010-0790 · Cited by 18
van de Laar, L., van den Bosch, A., Wierenga, A. T. J., Janssen, H. L. A., Coffer, P. J., & Woltman, A. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003977 · Cited by 18
“The used vectors contained wildtype STAT5a (STAT5a-wt) (17); STAT5a1*6, a constitutively active STAT5a mutant that harbors two point mutations, one in the transactivation domain (S710F) and the other in the DNA-binding domain (H298R) (16); or STAT5aD750, a dominant-negative STAT5a mutant that can bind to DNA but is un…”
BackgroundMethodCarretta, M., Brouwers-Vos, A. Z., Bosman, M. C. J., Horton, S. J., Martens, J. H. A., Vellenga, E., & Schuringa, J. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189102 · Cited by 16
“After ficoll separation of mononuclear cells, CD34 cells were enriched using a magnetically activated cell-sorting CD34 progenitor kit or automatically by using auto Macs (Miltenyi Biotech) as described previously [20,21] and cryopreserved until further use.”
Self-citationWang, L., Jiang, R., Shu-dan, S., Hua, Z.-S., Wang, J., & Wang, Y. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.9.3715 · Cited by 16
“…pathway, and activation of STAT5 has been shown to be indispensable to hematopoietic progenitor cells even CD34+ stem cells proceeding normal erythropoiesis based on up-regulating BCL-XL (Kieslinger et al., 2000; Testa, 2004; Schuringa et al., 2004; Olthof et al., 2008; Grebien et al., 2008).”
BackgroundExpression of Stat5A in tobacco chewing-mediated oral squamous cell carcinoma
Kar, P., & Supakar, P. C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.09.023 · Cited by 16
Oancea, C., Rüster, B., Brill, B., Roos, J., Heinßmann, M., Bug, G., Mian, A. A., Guillen, N., Kornblau, S. M., Henschler, R., et al. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.39 · Cited by 16
“Overexpression of a constitutively active STAT5 has been shown to increase self-renewal of human CD34+ HSCs [25, 26].”
BackgroundKimura, A., Martin, C., Robinson, G. W., Simone, J. M., Chen, W., Wickre, M. C., O’Shea, J. J., & Hennighausen, L. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141804 · Cited by 15
Geest, C. R., Buitenhuis, M., Vellenga, E., & Coffer, P. J. (2009) · Haematologica · doi:10.3324/haematol.2008.000471 · Cited by 14
“We and others have also shown that activation of the transcription factor STAT5 regulates proliferation, apoptosis and differentiation during erythroid and myeloid development.(24,31) To address the question of whether STAT5 signaling plays a critical role in regulating neutrophil differentiation in MDS, a bicistronic…”
BackgroundTsuji‐Takayama, K., Otani, T., Inoue, T., Nakamura, S., Motoda, R., Kibata, M., & Orita, K. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.06.004 · Cited by 14
Decreased expression of STAT5A predicts poor prognosis in osteosarcoma
Guo, Z., Tang, Y., Fu, Y., & Wang, J. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.01.008 · Cited by 13
Järås, M., Johnels, P., Ågerstam, H., Lassen, C., Rissler, M., Edén, P., Cammenga, J., Olofsson, T., Bjerrum, O. W., Richter, J., et al. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2008.11.003 · Cited by 12
“Because BCR/ ABL1 activates STAT5, and because STAT5 overexpression alone has been demonstrated to induce erythroid lineage differentiation [22], we speculated that the erythroid differentiation observed was STAT5-dependent.”
BackgroundCapala, M. E., Pruis, M., Vellenga, E., & Schuringa, J. J. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0151 · Cited by 13
“CFC assays were performed as previously described [35].”
Self-citationSaulle, E., Riccioni, R., Pelosi, E., Stafness, M., Mariani, G., Tuglie, G. D., Peschle, C., & Testa, U. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.10.005 · Cited by 12
Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Kan, W. L., Dhagat, U., Kaufmann, K. B., Hercus, T. R., Nero, T. L., Zeng, A. G. X., Toubia, J., Barry, E. F., Broughton, S. E., Gomez, G. A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1396 · Cited by 11
Metadata
- Authors
- Schuringa, J. J., Chung, K. Y., Morrone, G., & Moore, M. A. S.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2004-09-06
- Volume
- 200
- Issue
- 5
- Pages
- 623-635
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2212750
- OpenAlex
- W2117437672
- Cited by
- 140
- References
- 53
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 1 · 2017: 4 · 2016: 5 · 2015: 9 · 2014: 6 · 2013: 6 · 2012: 13
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl061401-04)
- National Heart, Lung, and Blood Institute (R01 HL 61401)
- National Cancer Institute (CA-09512, P01-CA59350, P01CA059350, T32CA009512)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- STAT5A, constitutive activation, hematopoietic stem cells, self-renewal, erythroid differentiation, hematopoiesis, CD34+ cells, umbilical cord blood, leukemic transformation, gene expression profiling, transcription factor signaling
- MeSH terms
- Animals, Cell Differentiation, Cell Division, Cell Line, Cell Transformation, Neoplastic, DNA-Binding Proteins, Erythrocytes, Fetal Blood, Flow Cytometry, Hematopoietic Stem Cells, Humans, Leukemia, Luminescent Proteins, Milk Proteins, Mutation, Phenotype, Retroviridae, Stem Cells, Time Factors, Immunoblotting, Signal Transduction, Trans-Activators, Polymerase Chain Reaction, Mice, SCID, Mice, Inbred NOD, Antigens, CD34, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Tumor Suppressor Proteins, Green Fluorescent Proteins, STAT5 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.